Back to Search
Start Over
Eli Lilly announces details of presentations at ESMO Congress 2023 on October 20-24 in Madrid
- Source :
- PharmaBiz. October 10, 2023
- Publication Year :
- 2023
-
Abstract
- Eli Lilly and Company has announced that data from studies of Verzenio (abemaciclib; a CDK4/6 inhibitor), Retevmo (selpercatinib; a rearranged during transfection [RET] inhibitor), and imlunestrant (an investigational oral selective [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.768374147